Targeting farnesyl pyrophosphate synthase of Trypanosoma cruzi by fragment-based lead discovery

Petrick, Joy Kristin

Targeting farnesyl pyrophosphate synthase of Trypanosoma cruzi by fragment-based lead discovery

Trypanosoma cruzi (T. cruzi) is the causative agent of Chagas disease (CD), which mostly affects underprivileged populations in South and Central America. The current standard of care for this disease are the two empirically discovered drugs benznidazole and nifurtimox. They show low efficacy, diffi...

Fuld beskrivelse

Gespeichert in:

Bibliografiske detaljer
Hovedforfatter:	Petrick, Joy Kristin
Andre forfattere:	Klebe, Gerhard (Prof. Dr.) (BetreuerIn (Doktorarbeit))
Format:	Dissertation
Sprog:	engelsk
Udgivet:	Philipps-Universität Marburg 2019
Fag:	Pharmakologie, Therapeutik mevalonate farnesyl pyrophosphate kissing bug Isoprenoid FPPS Fragment-basierte Wirkstoffforschung FDPS Chagas disease Chagas fragment based drug discovery Protein-Kristallograph protein cry isoprenoid Vernachlässigte Krankheit Farnesylpyroposphate-Synthase neglected disease Pharmacology & therapeutics, prescription drugs
Online adgang:	PDF-Volltext
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Vær først til at give en kommentarø!

Targeting farnesyl pyrophosphate synthase of Trypanosoma cruzi by fragment-based lead discovery

Lignende værker